Related Experiment Video

Updated: May 12, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

β-Ionone arrests cell cycle of gastric carcinoma cancer cells by a MAPK pathway

Hong-Wei Dong1, Shuang Zhang, Wen-Guang Sun

  • 1Harbin Medical University, 157 BaoJian Road, NanGang District, Harbin, 150081, People's Republic of China, donghongwei0824@yahoo.com.cn.

Archives of Toxicology
|March 29, 2013
PubMed

Insights

Beta-ionone, a carotenoid analog, effectively inhibits gastric cancer cell (SGC-7901) proliferation by arresting the cell cycle. It modulates mitogen-activated protein kinases (MAPKs) and related proteins, demonstrating its anti-cancer potential.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Beta-ionone, a beta-carotenoid analog, exhibits significant anti-proliferative properties in vitro and in vivo.
  • Gastric adenocarcinoma remains a significant global health concern, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To investigate the anti-proliferative mechanisms of beta-ionone in human gastric adenocarcinoma cells (SGC-7901).
  • To elucidate the effects of beta-ionone on cell cycle progression and mitogen-activated protein kinases (MAPKs) pathways.

Main Methods:

  • Treatment of SGC-7901 cells with varying doses of beta-ionone (25-200 μmol/L) for 24 hours.
  • Analysis of cell growth, DNA synthesis, and cell cycle distribution.
  • Assessment of protein expression for MAPKs (ERK, p38, JNK) and cell cycle regulators (Cdk4, Cyclin B1, D1, p27).

Main Results:

  • Beta-ionone dose-dependently inhibited SGC-7901 cell growth and DNA synthesis.
  • Cell cycle arrest at the G0/G1 phase was observed following beta-ionone treatment.
  • Modulation of MAPK pathways: decreased ERK, increased p38 and JNK expression.
  • Inhibition of Cdk4, Cyclin B1, D1, and increased p27 protein expression.

Conclusions:

  • Beta-ionone effectively arrests the cell cycle of gastric cancer cells (SGC-7901) at the G0/G1 phase.
  • The observed cell cycle arrest is likely mediated through the MAPK signaling pathway.
  • Beta-ionone demonstrates significant potential as an anti-cancer agent for gastric adenocarcinoma.

More Related Videos

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...